U.S. Stock Market News | Stocks related to weight loss drugs fell, Novo Nordisk dropped more than 4%
I'm PortAI, I can summarize articles.
週三，減肥藥概念相關股下跌，截至發稿，諾和諾德跌超 4%，禮來跌 1.6%，輝瑞跌 0.34%。哈佛大學附屬醫院 Massachusetts Eye and Ear 醫生們的分析結果顯示，諾和諾德暢銷的減肥藥 Ozempic 和 Wegovy 似乎與患上罕見視覺功能喪失的風險上升有關。針對病歷的研究結果顯示，相比那些使用其他品牌減肥藥的人，使用諾和諾德減肥藥來減肥的患者們患上非動脈性前部缺血性視神經病變 (NAION) 的可能性要高出七倍。
智通財經 APP 獲悉，週三，減肥藥概念相關股下跌，截至發稿，諾和諾德 (NVO.US) 跌超 4%，禮來 (LLY.US) 跌 1.6%，輝瑞 (PFE.US) 跌 0.34%。哈佛大學附屬醫院 Massachusetts Eye and Ear 醫生們的分析結果顯示，諾和諾德暢銷的減肥藥 Ozempic 和 Wegovy 似乎與患上罕見視覺功能喪失的風險上升有關。針對病歷的研究結果顯示，相比那些使用其他品牌減肥藥的人，使用諾和諾德減肥藥來減肥的患者們患上非動脈性前部缺血性視神經病變 (NAION) 的可能性要高出七倍。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments